Table 2.
CMR findings of patient population (n = 10)
| Case No. | Age | LVEF (%) | Delayed enhancement | Medical treatment | 6 month f/u LVEF (%) |
| 1 | 33 | 32 | Lateral, septal | ACEI, beta blockers | 55 |
| 2 | 41 | 28 | Lateral | ACEI, beta blockers | 60 |
| 3 | 27 | 30 | Lateral | ACEI, beta blockers | 40 |
| 4 | 39 | 25 | Lateral | ACEI, beta blockers | 65 |
| 5 | 44 | 35 | Lateral, septal | ACEI, beta blockers | 60 |
| 6 | 38 | 30 | Lateral | ACEI, beta blockers | 40 |
| 7 | 56 | 25 | Lateral | ACEI, beta blockers | 30 |
| 8 | 45 | 24 | Lateral | ACEI, beta blockers | 55 |
| 9 | 32 | 30 | Lateral | ACEI, beta blockers | 35 |
| 10 | 40 | 34 | Lateral | ACEI, beta blockers | 58 |
LVEF, left ventricular ejection fraction; ACEI, angiotensin converting enzyme inhibitor.